Top Medical Oncologists Join Deciphera Pharmaceuticals Scientific Advisory Board

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, announced today that three new members have joined its Scientific Advisory Board, which serves as a strategic resource to Deciphera as it develops its switch-pocket inhibitors for the treatment of cancers.

Help employers find you! Check out all the jobs and post your resume.